+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Avycaz"

From
From
Avycaz- Drug Insight, 2019 - Product Thumbnail Image

Avycaz- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Avycaz is a brand of antibiotics used to treat a variety of bacterial infections. It is a combination of ceftazidime, an antibiotic, and avibactam, a beta-lactamase inhibitor. Avycaz is used to treat complicated intra-abdominal infections, complicated urinary tract infections, and hospital-acquired bacterial pneumonia. It is also used to treat infections caused by certain Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Avycaz is a relatively new antibiotic on the market, having been approved by the U.S. Food and Drug Administration in 2015. It is manufactured by Allergan, a subsidiary of Pfizer, and is available in both intravenous and oral formulations. Other companies that produce antibiotics similar to Avycaz include Merck, AstraZeneca, and GlaxoSmithKline. Show Less Read more